Revolution Medicines, Inc. · NASDAQ:RVMD
Patel Sushil sold 5,580 Revolution Medicines, Inc. shares (Form 4)
Traded Jun 29, 2026 · Filed Jul 1, 2026
On Jun 29, 2026, Patel Sushil (Director) sold 5,580 Revolution Medicines, Inc. shares at an average US$187.99 for US$1.05M under a trading plan, leaving 21,656 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 5,580 shares
- Price
- US$187.99 average (US$183.17 to US$192.61)
- Value
- US$1.05M
- Holding after
- 21,656 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Option exercise | 2,955 | US$37.54 | 27,236 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 300 | US$183.17 | 26,936 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 900 | US$184.59 | 26,036 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 1,100 | US$185.90 | 24,936 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 858 | US$186.92 | 24,078 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 300 | US$187.83 | 23,778 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 100 | US$188.57 | 23,678 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 600 | US$190.55 | 23,078 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 541 | US$191.87 | 22,537 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 881 | US$192.61 | 21,656 | Direct |
Source
Related
- Revolution Medicines, Inc.
- Patel Sushil
- Revolution Medicines, Inc. shareholders
- Form 4 · Patel Sushil · Jun 23, 2026
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026